tiprankstipranks
Trending News
More News >
Entrada Therapeutics Inc (TRDA)
:TRDA
US Market

Entrada Therapeutics Inc (TRDA) Income Statement

Compare
144 Followers

Entrada Therapeutics Inc Income Statement

Last quarter (Q3 2025), Entrada Therapeutics Inc's total revenue was $1.61M, a decrease of -91.75% from the same quarter last year. In Q3, Entrada Therapeutics Inc's net income was $-44.13M. See Entrada Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 210.78M$ 129.01M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 210.78M$ 129.01M$ 0.00$ 0.00$ -326.00K
Operating Expenses
$ 163.77M$ 132.18M$ 97.25M$ 51.13M$ 26.34M
Depreciation and Amortization
$ 3.77M$ 2.84M$ 1.90M$ 1.12M$ 326.00K
EBITDA
$ 47.01M$ -321.00K$ -95.35M$ -50.01M$ -26.20M
Operating Income
$ 47.01M$ -3.16M$ -97.25M$ -51.13M$ -26.67M
Other Income/Expenses
$ 19.47M$ 15.22M$ 2.63M$ -31.00K$ 144.00K
Pretax Income
$ 66.48M$ 12.06M$ -94.62M$ -51.16M$ -26.52M
Net Income
$ 65.63M$ -6.68M$ -94.62M$ -51.16M$ -26.52M
Per Share Metrics
Basic EPS
$ 1.76$ -0.20$ -2.79$ -1.60$ -0.84
Diluted EPS
$ 1.68$ -0.20$ -2.79$ -1.60$ -0.84
Weighted Average Shares Outstanding
37.31M 33.05M 31.29M 31.22M 31.25M
Weighted Average Shares Outstanding (Diluted)
39.00M 33.05M 31.29M 31.22M 31.25M
Currency in USD

Entrada Therapeutics Inc Earnings and Revenue History